Skip to main content
. 2014 Apr 2;33(6):1491–1497. doi: 10.3892/ijmm.2014.1715

Figure 2.

Figure 2

Western blot analysis was used to investigate the effects of rapamycin on components of the mammalian target of rapamycin (mTOR) pathway. (A) Phospho-p70S6 kinase (p70S6K) expression levels were decreased following treatment with rapamycin in a dose-dependent manner. (B) Analysis of the effects of treatment with rapamycin and/or U0126. Treatment with rapamycin resulted in a dose-dependent increase in LC-3II and Atg12-Atg5 complex expression. On the contrary, p62/SQSTM1 expression was decreased in a dose-dependent manner. Cleaved PARP and cleaved caspase-3 expression was increased by rapamycin and rapamaycin-plus-U0126 treatment. Rap, rapamycin.